Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2007
12/05/2007CN101081073A Selenium germanium peptide jujube tea paste for effecting radical cure of hepatitis B
12/05/2007CN101081072A Selenium germanium peptide jujube tea paste for effecting radical cure of sugar diabetes
12/05/2007CN101081053A Method for producing wintertide jujube bud-tea
12/05/2007CN101081052A Method for making edible 'MilpaAita Cacti' tea
12/05/2007CN101081049A Green grape health tea
12/05/2007CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007CN100352843C Kdr peptides and vaccines comprising the same
12/05/2007CN100352835C Corn albumen powder polypeptide, its separation method and uses
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352810C Fumagillol derivatives and processes for preparing the same
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352804C 酰胺衍生物 Amide derivatives
12/05/2007CN100352505C A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes
12/05/2007CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/05/2007CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor
12/05/2007CN100352493C Method of treating tumors
12/05/2007CN100352492C Health care medicinal pillow
12/05/2007CN100352491C Fat-reducing tea and preparation method trereof
12/05/2007CN100352480C Pharmaceutical composition, its preparation method and usage
12/05/2007CN100352478C Novel use of bighead atractylodes rhizome in pharmacy
12/05/2007CN100352457C Apocynum extract and extracting method thereof
12/05/2007CN100352456C Application of yacon leaf extract
12/05/2007CN100352455C Ginkgo Damo freeze-drying prepn. and its prepn. method
12/05/2007CN100352450C Albumen removed extraction of calf blood for injection and its preparing process
12/05/2007CN100352442C Pharmaceutical combinations
12/05/2007CN100352441C Combination therapy for the treatment of cancer
12/05/2007CN100352439C Compound nicotinic acid slow releasing capsule and its preparing method
12/05/2007CN100352438C Milrione lyophilied powder injection and its preparing method
12/05/2007CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
12/05/2007CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation
12/05/2007CN100352428C Capsule containing ginkgo leaf extract
12/04/2007US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice
12/04/2007US7304089 Preparation for improved dietary utilisation
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders
12/04/2007US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007US7304072 Spiro compounds
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304040 Suppression of post-transplant arteriosclerosis
12/04/2007US7304031 Methods and means for producing proteins with predetermined post-translational modifications
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007US7303765 Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/04/2007US7303758 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2233315C Pharmaceutical compositions containing hydroximic acid derivatives
12/04/2007CA2212205C Use of xanthine derivatives for the modulation of apoptosis
11/2007
11/29/2007WO2007137040A2 7-(acryloyl) indole compositions and methods for making and using same
11/29/2007WO2007136125A1 Compound having heterocyclic ring and use thereof
11/29/2007WO2007136085A1 Spiro tetracyclic compound
11/29/2007WO2007136068A1 Process for producing composition having high polyphenol content
11/29/2007WO2007136042A1 Ameliorating agent for brain damage
11/29/2007WO2007135992A1 Cerebral vasospasm inhibitor
11/29/2007WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007WO2007135774A1 Oral liquid preparation composition containing herbal medicine
11/29/2007WO2007135417A1 Benzotriazepinone derivatives
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007134870A1 Bilayer tablet for preventing cardiovascular events
11/29/2007WO2007134867A2 Treating muscular disorders and improving muscular function
11/29/2007WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007WO2007134485A1 Aporphine and oxoaporphine compounds and pharmaceutical use thereof
11/29/2007WO2007117559A3 Renin inhibitors
11/29/2007WO2007117557A3 Diaminopropanol renin inhibitors
11/29/2007WO2007113365B1 Dairy-protein-derived peptides with angiotensin 1 converting enzyme inhibitory activity
11/29/2007WO2007112136A3 Methods and systems for treating injured cardiac tissue
11/29/2007WO2007100466A3 Nanoparticulate carvedilol formulations
11/29/2007WO2007098964A3 Pyrrazole derivatives as sigma receptors antagonists
11/29/2007WO2007088460A3 Tgf-beta modulators and use thereof
11/29/2007WO2007078335A3 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
11/29/2007WO2007056324A3 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent
11/29/2007WO2006133955A8 Adamts13-comprising compositions having thrombolytic activity
11/29/2007WO2006079539A3 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
11/29/2007WO2006072612A3 Triazolophthalazines as pde2- inhibitors
11/29/2007US20070277250 Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276050 Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases
11/29/2007US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
11/29/2007US20070276039 Pharmaceutical uses for alpha2delta ligands
11/29/2007US20070276037 Cytoprotective Effects of Ethyl Pyruvate
11/29/2007US20070276015 Crystal modification of torasemide
11/29/2007US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007US20070275997 Perhexiline For Treating Chronic Heart Failure
11/29/2007US20070275995 Thiobenzimidazole derivatives
11/29/2007US20070275989 Therapeutic Treatment
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
11/29/2007US20070275958 Use of Oxicam Compounds
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275917 Rna Capable of Suppressing Expression of Klf5 Gene
11/29/2007US20070275909 Useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels; carbohydrate-containing pyrazolidinone or oxazolidinone derivatives, for example
11/29/2007US20070275901 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament
11/29/2007US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
11/29/2007US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
11/29/2007US20070275097 Cosmetic And/Or Dermatological Preparation And Use Thereof In The Regulation Of Skin Capillary Blood Flow
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1595